9:41
isothrive.com
Screenshot of isothrive.com
isothrive.com favicon

isothrive.com

9 technologies
VerifiedVisit170/mo$2M139 Tech7 Leads
Deep Dive

Microbiome Therapeutics: The ISOThrive Deep Dive

A tiny biotech with a massive mission to correct dysbiosis

ISOThrive isn't just another biotech chasing the microbiome hype. They're building proprietary, digestion-resistant carbohydrates designed to target specific bacteria and correct dysbiosis—a potentially disease-modifying mechanism of action in high-unmet-need states.

13
employees
$2M
annual revenue
100%
direct traffic
170
monthly visits

"In a crowded microbiome space, ISOThrive is playing the long game with proprietary assets and a focused, capital-efficient model."

The Lean Biotech Play

With just 13 employees and $2M in revenue, ISOThrive is operating with a precision focus. Their team is led by seasoned operators like Jack Oswald (CEO/CTO) and Peter Swann (CMO), signaling deep technical and clinical expertise. This isn't a company burning cash on bloat; it's a lean team executing a focused R&D strategy.

The Science Edge

Their core innovation lies in 'digestion-resistant carbohydrates'—a specific tool to target specific bacteria. This approach moves beyond generic probiotics or prebiotics, aiming for a disease-modifying effect. The proprietary nature of their assets suggests a strong IP moat, a critical factor for biotech investors.

The traffic data is telling. With 100% direct traffic and only 170 monthly visits, ISOThrive isn't playing the SEO or content marketing game. This is typical for early-stage biotechs focused on B2B partnerships and pharma deals rather than consumer-facing products. Their contact page lists specific emails for pharma inquiries, reinforcing this strategic focus.

  • Proprietary, digestion-resistant carbohydrate platform
  • Disease-modifying MoA targeting microbiome dysbiosis
  • Leadership with deep technical and clinical expertise
  • Capital-efficient model with $2M revenue and 13 employees
No consumer-facing products
Targeted, proprietary therapeutics
No mass-market marketing
B2B/pharma partnership focus
No broad, undifferentiated probiotics
Disease-modifying MoA in high-unmet-need states

The Verdict: A High-Potential Niche Player

ISOThrive is a focused biotech with proprietary science and a lean execution model—exactly what strategic pharma partners and savvy biotech investors look for.

What tech stack does Isothrive use?

15 detected
Analytics & Marketing1
Web Standards1
Frontend Frameworks1
Tracking & Analytics6
G
Google Analytics
H
Hotjar
H
Hotjar
G
Google APIs
H
Hotjar
G
Google Static

How much traffic does Isothrive get?

Traffic & Engagement

170
Monthly Visits
2.9
Pages/Visit
1:44
Avg. Duration
35%
Bounce Rate
Monthly Traffic Trend+2%
166
Oct 2025
Oct
337
Nov 2025
Nov
170
Dec 2025
Dec

Traffic Sources

Direct
100%

Where is Isothrive's audience located?

🌍100.0%

How is Isothrive's SEO?

Open Graph Image

OG Image preview
og:image

http://static1.squarespace.com/static/5e1a3a25ba9eea29420af80d/t/5e1ba0cb3a904b6e1b59d028/1578868941175/ISOcolorlogo.fw.png?format=1500w

Meta Tags

title35 chars

ISOThrive - Microbiome Therapeutics

description293 chars

Treating Chronic Disease Caused by Microbiome Dysbiosis. We develop novel, proprietary digestion-resistant carbohydrates that target specific bacteria to correct microbiome dysbiosis. Correcting dysbiosis is a potentially disease modifying MoA in numerous disease states of high unmet need.

og:title

ISOThrive - Microbiome Therapeutics

og:description

Treating Chronic Disease Caused by Microbiome Dysbiosis. We develop novel, proprietary digestion-resistant carbohydrates that target specific bacteria to correct microbiome dysbiosis. Correcting dysbiosis is a potentially disease modifying MoA in numerous disease states of high unmet need.

languageEN-US

H1 Tags

h1Microbiome Therapeutics
h1Assets
h1Contact Us

Schema Types

WebSite

Who works at Isothrive?

Loading leads...

What do customers think of Isothrive?

No Trustpilot reviews available for this company.

Frequently Asked Questions about Isothrive

What is Isothrive's Revenue?
Isothrive generates approximately $2M in annual revenue. With 13 employees, that's $155,000 per employee.
What does Isothrive do?
Treating Chronic Disease Caused by Microbiome Dysbiosis. We develop novel, proprietary digestion-resistant carbohydrates that target specific bacteria to correct microbiome dysbiosis. Correcting dysbiosis is a potentially disease modifying MoA in numerous disease states of high unmet need.
How fast is Isothrive growing?
Isothrive employee count has changed by 8% year over year.
What technologies does Isothrive use?
Isothrive uses 9 technologies across their website including Fonts, CMS, Analytics & Marketing. Key technologies include Google Fonts, Squarespace, Hotjar.
Who are Isothrive's competitors?
Isothrive's main competitors include BrightSpec, Serpin Pharma, Parabon, Bode Technology, SystemLink. These companies operate in similar markets and compete for the same customer base.

Export Data

Unlock all exports

Download CSVs, JSONs & full reports

What are Isothrive's key pages?

Export isothrive.com Data

Download the complete tech stack, analytics, leads, and company data for isothrive.com in JSON or CSV format. Use it for your sales pipeline, competitive analysis, or research.

Raw JSON Data

Click "Show" to view the raw API response data

About isothrive.com

Treating Chronic Disease Caused by Microbiome Dysbiosis. We develop novel, proprietary digestion-resistant carbohydrates that target specific bacteria to correct microbiome dysbiosis. Correcting dysbiosis is a potentially disease modifying MoA in numerous disease states of high unmet need.

Company Overview

isothrive.com
Website
170
Monthly Visitors
9
Technologies
7+
Employees

isothrive.com Key Pages

Technology Stack

isothrive.com uses 9 technologies across their website including Google Fonts, Squarespace, Hotjar, and more.

Fonts

Google Fonts

CMS

Squarespace

Analytics & Marketing

Hotjar

Performance

Lazy Loading, Priority Hints

Web Standards

Twitter Cards

CSS Frameworks

Bootstrap, Tailwind CSS

Traffic & Audience

170
Monthly Visits
35%
Bounce Rate
2.9
Pages/Visit
1:44
Avg. Duration

isothrive.com receives approximately 170 monthly visitors. The website has a bounce rate of 35% with visitors viewing an average of 2.9 pages per visit. Users spend an average of 1:44 on the site.

The majority of isothrive.com's traffic comes from .

Frequently Asked Questions

What is isothrive.com?
Treating Chronic Disease Caused by Microbiome Dysbiosis. We develop novel, proprietary digestion-resistant carbohydrates that target specific bacteria to correct microbiome dysbiosis. Correcting dysbiosis is a potentially disease modifying MoA in numerous disease states of high unmet need.
What technologies does isothrive.com use?
isothrive.com uses 9 technologies including Google Fonts, Squarespace, and 3 more. View the full tech stack analysis above.
How do I contact isothrive.com?
You can contact isothrive.com via email at [email protected] or through their contact page.
How popular is isothrive.com?
isothrive.com receives approximately 170 monthly visitors. Traffic is declining by 49.6% month-over-month.

Related Searches

isothrive.com pricingisothrive.com reviewsisothrive.com alternativesisothrive.com loginisothrive.com careerswhat is isothrive.comisothrive.com tech stackisothrive.com contactisothrive.com vs competitorsisothrive.com featureshow to use isothrive.comisothrive.com integrations

This page provides publicly available information about isothrive.com. Data is collected from various public sources and may not always be up to date. For the most accurate information, please visit isothrive.com directly at https://isothrive.com.